Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-11 · accession 0000950170-24-105616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-09-11 | 2024-09-11 | AXSM | Saad Mark E | Dir | S - Sale+OE | $91.31 | -11.0K | 10.0K | -52% | -$1.01M |
| DT | 2024-09-11 | 2024-09-11 | AXSM | Saad Mark E | Dir | M - OptEx | $3.67 | +11.0K | 21.0K | +110% | +$40.4K |
| DT | 2024-09-11 | 2024-09-11 | AXSM | Saad Mark E | Dir | M - OptEx | $0.00 | -11.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-11 | S | D | 11,016 | $91.31 | 10,002 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $90.25 and $92.90. |
| 2 | Common | Common Stock | 2024-09-11 | M | A | 11,016 | $3.67 | 21,018 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-09-11 | M | D | 11,016 | $0.00 | 0 | D | $3.67 · 2015-09-16 to 2024-09-16 | 11,016 Common Stock |